What's New in the Management of Pancreatic Cancer? (C)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer. Learn more about ACS Accreditation/Verification Requirements.
Though a deadly disease, there have been numerous advances in the care of the pancreatic cancer patient. This session will cover the latest information in imaging the patient preoperatively, the use of neoadjuvant therapy, and new techniques in surgery.
Moderator: Robert C. Martin, MD, FACS, Louisville, KY
Co-Moderator: Vinod Balachandran, MD, FACS, New York, NY
Surgical Quality in Pancreatectomy: Whipple and Distal Pancreatectomy
Syed A. Ahmad, MD, FACS, Cincinnati, OH
The Use of Molecular Subtyping: Should All Newly Diagnosed Pancreatic Ductal Adenocarcinoma (PDA) undergo Subtyping?
Jen Jen Yeh, MD, FACS, Chapel Hill, NC
Pancreatectomy Technique: Robotic vs. Lap vs. Open
Steven J. Hughes, MD, FACS, Gainesville, FL
Surgeons and Pancreatic Cancer Clinical Trials: How to Lead and Initiate a Pancreatic Clinical Trial
David K. Chang, MD, Glasgow, United Kingdom
Sponsored by the Advisory Council for General Surgery and the Commission on Cancer
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
For questions about the course, please contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures).
Faculty and Disclosures
David K. Chang, MBBS, MS, FRACS, FRCS(Glasg), PhD - Celgene: Investigator Initiated Clnical Trial research funding support: Translational Chief Investigator of Investigator Initiated Trial
Jen Jen Yeh MD, FACS - Nothing to Disclose
Robert C. Martin MD, FACS - Nothing to Disclose
Steven J. Hughes MD, FACS - Nothing to Disclose
Syed A. Ahmad, MD, FACS - Abbvie Inc.: Honorarium: Speaker Bureau; Portola (Andexxa): Honoraria: Speakers Bureau
Vinod Balachandran, MD, FACS - Bristol Myers Squibb: Research funding:
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure
David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure
Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit